Key market opportunities include mastering API manufacturing complexities to ensure quality and compliance, navigating EU and USA regulatory frameworks, adhering to GMP and GDP standards, and adapting ...
BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today reported strong growth in 2022 in both its ...
BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...
C2 Pharma, which concentrates on hard-to-make ingredients, has picked up a new supply of digoxin. The deal will give it two supplies of API for making the sometimes-difficult-to-get drug. The ...
Vion Pharmaceuticals Extends Agreement With SAFC Pharma Partnership for Cloretazine API Manufacturing ST. LOUIS, March 21 -- SAFC, a member of the Sigma-Aldrich Group, continues its appointment as a ...
KD Pharma, a Swiss API maker of omega-3 products, has snapped up a manufacturing site in Seal Sands, U.K., for an undisclosed price. The company said the acquisition will allow it to expand capacity ...
BUFFALO, N.Y., Jan. 23, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and ...
Eurofins CDMO Alphora is excited to announce the expansion of its Active Pharmaceutical Ingredient (API) manufacturing ...
ST Pharm, a specialized contract development and manufacturing organization (CDMO) subsidiary of Dong-A Socio Holdings, said on the 16th that it signed a contract to supply active pharmaceutical ...
SINGAPORE, Nov. 28, 2018 /PRNewswire/ -- ST Pharm Co Ltd was recognized with the Global API Manufacturing (Oligonucleotide) Growth Excellence Leadership award at the annual Frost & Sullivan ...
USA-based SQ Innovation has struck a long-term supply agreement with Italian active pharmaceutical ingredient (API) ...
BROOKLYN, New York, Oct. 14, 2020 (GLOBE NEWSWIRE) -- According to Global Market Estimates, the Indian API Market will grow rapidly at a CAGR of 8.57% during the 2020-2026 phase. The Indian drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results